We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

241 hedge funds and large institutions have $3.05B invested in Bio-Rad Laboratories Class A in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 81 increasing their positions, 89 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

592% more call options, than puts

Call options by funds: $5.99M | Put options by funds: $866K

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

32% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 22

11% more capital invested

Capital invested by funds: $2.74B → $3.05B (+$314M)

2% more funds holding

Funds holding: 236 → 241 (+5)

0.18% less ownership

Funds ownership: 78.78% → 78.6% (-0.18%)

9% less repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 89

Holders
241
Holders Change
+5
Holders Change %
+2.12%
% of All Funds
6.43%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
29
Increased
81
Reduced
89
Closed
22
Calls
$5.99M
Puts
$866K
Net Calls
+$5.13M
Net Calls Change
+$2.34M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$45.5M
2
LHC
Lodge Hill Capital
New York
+$19.8M
3
CS
Credit Suisse
Switzerland
+$13.3M
4
HCMT
Highland Capital Management (Texas)
Texas
+$9.56M
5
Millennium Management
Millennium Management
New York
+$9.36M

Top Sellers

1
LCS
Levin Capital Strategies
New York
-$63.4M
2
EA
Emerald Acquisition
Washington
-$16.9M
3
HSBC Holdings
HSBC Holdings
United Kingdom
-$7.63M
4
First Trust Advisors
First Trust Advisors
Illinois
-$5.62M
5
NIMC
NWQ Investment Management Company
California
-$4.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$36.3M +$372K +2,452 +1%
PAMP
27
Polar Asset Management Partners
Ontario, Canada
$30.9M +$9.06M +59,717 +46%
GIM
28
Granahan Investment Management
Massachusetts
$28.7M -$2.79M -18,400 -10%
Norges Bank
29
Norges Bank
Norway
$26.4M – – –
RA
30
Royce & Associates
New York
$24.6M -$4.34M -28,600 -16%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$23.7M +$1.41M +9,292 +7%
TM
32
Tikvah Management
North Carolina
$22.6M – – –
SGA
33
Sector Gamma AS
Norway
$22.4M +$525K +3,460 +3%
Franklin Resources
34
Franklin Resources
California
$21.5M – – –
EARNEST Partners
35
EARNEST Partners
Georgia
$21.5M -$414K -2,727 -2%
LHC
36
Lodge Hill Capital
New York
$21.4M +$19.8M +130,700 New
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$19.5M +$729K +4,800 +4%
PCM
38
Portolan Capital Management
Massachusetts
$17.6M +$3.33M +21,946 +26%
TA
39
Tamarack Advisers
California
$17.5M +$5.77M +38,000 +54%
Charles Schwab
40
Charles Schwab
California
$15.9M +$1.39M +9,162 +10%
NFA
41
Nationwide Fund Advisors
Ohio
$14.6M -$1.77M -11,632 -12%
Principal Financial Group
42
Principal Financial Group
Iowa
$13.3M +$406K +2,677 +3%
HP
43
Hosking Partners
United Kingdom
$13.2M +$1.45M +9,528 +13%
ICOM
44
Investment Counselors of Maryland
Maryland
$13.1M -$1.83M -12,030 -13%
TRSOTSOK
45
Teachers Retirement System of the State of Kentucky
Kentucky
$12.9M +$710K +4,678 +6%
First Trust Advisors
46
First Trust Advisors
Illinois
$12.6M -$5.62M -37,014 -33%
SAM
47
Sentinel Asset Management
Vermont
$12.4M – – –
PPA
48
Parametric Portfolio Associates
Washington
$12M -$2.73M -17,957 -20%
MAM
49
Martingale Asset Management
Massachusetts
$11.6M -$4.25M -27,995 -28%
EAM
50
EverPoint Asset Management
Connecticut
$11.5M – – –
1
2
3 4 5

BIO Hedge Fund Activity: Q3 2016 in Review

241 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2016, worth a combined $3.05B — up 11% from $2.74B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new BIO positions and 22 closed out — a net gain of 7 holders — while 81 added to existing stakes and 89 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $45.5M. The largest seller was Levin Capital Strategies, cutting an estimated $63.4M.

  • 241 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2016, up from 236 in Q2 2016.
  • Funds reported $3.05B of Bio-Rad Laboratories Class A stock for Q3 2016, up 11% quarter-over-quarter.
  • 29 funds opened new Bio-Rad Laboratories Class A positions in Q3 2016 and 22 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2016 was Morgan Stanley, an estimated $45.5M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2016 was Levin Capital Strategies, an estimated $63.4M sold.

Based on aggregated 13F filings for Q3 2016.